We report the case of a 48-year-old woman who presented with bilateral parotid gland enlargement as the initial manifestation of primary Sjögren syndrome. Magnetic resonance imaging demonstrated multiple areas of lowintensity signal mixed with foci of high-intensity signal, a fi nding suggestive of Sjögren syndrome. Autoimmune blood tests for Sjögren syndrome were positive, and a sublabial biopsy confi rmed the diagnosis. Investigations for other conditions, including human immunodefi ciency virus infection, were negative. Aft er 5 years of follow-up, the parotid swellings remained essentially unchanged. We discuss the etiology of multicystic parotid gland pathology, its involvement in Sjögren syndrome, and the risk of lymphoma.
Introduction
Sjögren syndrome is a chronic autoimmune disease characterized by mononuclear infi ltrations that produce destructive lesions in exocrine glands, primarily the lacrimal and salivary glands. 1 In primary Sjögren syndrome, gland involvement occurs without any involvement of associated autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematous, and scleroderma. 1 Based on a study of autopsy reports, Hudson estimated that the incidence of Sjögren syndrome was 1 case per 255 population; as such, it was second to only rheumatoid arthritis as the most common autoimmune disease. 2 In this article, we present the case of a middle-aged woman with primary Sjögren syndrome.
Case report
A 48-year-old woman was referred to our Department of Otolaryngology for evaluation of a 6-week history of progressive swelling of both parotid glands. She was otherwise well, with no associated symptoms and no signifi cant family history.
Physical examination confi rmed bilateral, diff use enlargement of both parotid glands. No other abnormality was found in the upper aerodigestive tract, and fi ndings on the systemic examination were normal. Th e peripheral blood picture was normal, but the erythrocyte sedimentation rate was 56 mm/hr. Findings on immunology, radiology, and histology all suggested a working diagnosis of Sjögren syndrome:
• Immunoglobulin measurements revealed an IgG level of 5.8 g/L, an IgM level of 1.3 g/L, and an IgA level of 1.5 g/L. Immunologic screening also revealed an elevated antinuclear antibody level (at a 1:80 dilution) and positivity for anti-Ro/SSA and anti-La/SSB antibodies. Serology for human immunodefi ciency virus (HIV) was negative.
• Magnetic resonance imaging (MRI) showed bilateral involvement of both the superfi cial and deep lobes of the parotid glands. Multiple areas of low signal intensity were seen on T1-weighted imaging, and foci of high signal were seen on T2 weighting (fi gure).
• A sublabial biopsy of the minor salivary glands showed infi ltration by a mixed population of B and T lymphocytes, which formed lymphoepithelial lesions (epimyoepithelial islands). No evidence of malignancy was found. the parotid gland. In our patient, MRI showed multiple areas of low signal intensity on T1 weighting and foci of high signal on T2 weighting; such a fi nding is known as the "salt and pepper appearance, " and it is suggestive of Sjögren syndrome. Th e hypointense foci are reported to represent a dilated ductal system, while the hyperintense foci represent focal lymphocytic aggregation. 10 Histologic confi rmation is an important factor in the process of diagnosing Sjögren syndrome. FNAC of the involved gland can show the presence of numerous lymphocytes mixed with follicular center cells, plasma cells, and histiocytes, which indicate a benign lymphoepithelial disease consistent with Sjögren syndrome. However, the identifi cation of lymphoepithelial lesions can be a rare occurrence; histology appears to be the gold standard in such cases. Th erefore, histology from biopsy of the sublabial salivary glands is a vital diagnostic investigation. Th e typical histologic fi nding in Sjögren syndrome is a massive, mixed lymphocytic infi ltration of the glandular tissue with atrophy of the glands and the presence of lymphoepithelial lesions. 2 Patients with Sjögren syndrome have a greater than 40-fold higher risk of developing lymphoma. 11 Th e predictive factors for lymphoma include the presence of persistent parotid gland enlargement, lymphadenopathy, splenomegaly, glomerulonephritis, and mixed monoclonal cryoglobulinemia. 12 Th e lymphoma in Sjögren syndrome is usually a non-Hodgkin lymphoma (NHL); most are marginal-zone B-cell lymphomas. Th e prevalence of NHL in Sjögren syndrome is about 4%. 11 At 5 years of follow-up, the patient was concerned about the gradually progressing asymmetric appearance of the parotid glands (the right gland was slightly larger). A repeat MRI and performance of fi ne-needle aspiration cytology (FNAC) under ultrasound guidance yielded results similar to those obtained at the initial presentation-particularly the destructive process in the parotid glands consistent with Sjögren syndrome. Th e patient was reassured, and aft er a discussion of surgery and its inherent risks, we jointly decided to adopt a wait-and-see policy.
Discussion
Most (as many as 66%) patients with primary Sjögren syndrome experience major salivary gland enlargement. 3 Th e enlargement may be fi xed or it may be intermittent with varying periods of remission. Clinically, there may be unilateral or bilateral swelling of the salivary glands; the parotid gland is most oft en involved. Benign lymphoepithelial cysts are the most common manifestation of parotid swelling. 4 Multiple cysts of various sizes in the parotid have been described, although large cysts are rare. 5, 6 Other cystic conditions such as mucocele, branchial cyst, cystic Warthin tumor, and HIV-related parotid cyst must be ruled out on clinical and histologic grounds. 7 Other masses that occur with parotid neoplasms include mucoepidermoid cysts, adenoid cystic carcinomas, and undiff erentiated carcinomas. 8, 9 MRI has become increasingly useful in detecting infl ammatory changes and in diagnosing tumors of In patients who present with persistent parotid gland enlargement, the possibility of a localized lymphoma must be ruled out. Regular follow-up of patients with Sjögren syndrome is essential for early detection of signs suggestive of lymphoma. Each follow-up visit should include a clinical examination of the neck to look for signs of lymphadenopathy and of the parotid gland to look for asymmetry and changes in size. Clinicians should also look for associated B symptoms-that is, recurring fever, night sweats, constant fatigue, and unexplained weight loss. If a malignancy is suspected on clinical grounds, the patient should undergo a repeat MRI followed by FNAC.
On MRI, features such as asymmetric parotid swelling and intermediate signals on T1 and T2 weighting consistent with asymmetric enlargement of the deep cervical chain confi rm a suspicion of lymphoma and should prompt a biopsy. FNAC of the parotid gland under ultrasound guidance can exclude the possibility of high-grade NHL or Hodgkin lymphoma. Th e presence of a mixed population of B and T lymphocytes of various sizes excludes a low-grade lymphomatous infi ltration; this fi nding could be confi rmed by immunohistochemical studies looking for a mixed population of CD3-reactive T cells and CD20-reactive B cells. However, if the FNAC result is not helpful and clinical suspicion has been raised, then a biopsy would be appropriate. Patients should be made aware of the risk of injury to the facial nerve before the biopsy is carried out.
In conclusion, multicystic parotid gland disease poses a diagnostic riddle. It is associated with several diff erent and interesting pathologies, and it might be the only atypical presentation of primary Sjögren syndrome. Th e recommended diagnostic investigations are immunology, radiology, and histology. A high index of suspicion is needed to exclude serious pathology such as HIV infection and lymphoma. A long-term and careful follow-up is important, especially in young patients, to allow for prompt recognition of a lymphoma.
